AccessibilityHelp
Star Combo Pharma logo

Star Combo Pharma(ASX) S66

Market CapA$18.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-81%
5 Year-49%
1 Year-28%
1 Month+2%
A$0.14
+0.00%
+0.00Today
Star Combo Pharma last closing stock price
MetricPriceDate
Last closeAUD 0.142026-10-21
Star Combo Pharma stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.43%AUD 0.142026-10-07
1 month+2.43%AUD 0.142026-09-18
3 month+30.36%AUD 0.112026-07-21
Year to date-44.85%AUD 0.252025-12-31
1 year-28.3%AUD 0.202025-10-20
3 year+35.68%AUD 0.102023-10-17
5 year-49.41%AUD 0.282021-10-21
Since inception-81.16%AUD 0.742018-05-16

Star Combo Pharma Financials at a Glance

Market Cap

A$18.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$51.38M

Net Income (TTM)

A$5.64M

EPS (TTM)

A$0.00

P/E Ratio

48.28

Dividend

A$0.00

Beta (Volatility)

-0.22 (Low)

Price

A$0.14

Volume

0

Open

A$0.14

Previous Close

A$0.14

Daily Range

A$0.14 - A$0.14

52-Week Range

A$0.10 - A$0.28

Estimated Earnings Date

Feb 24, 2026

S66 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Star Combo Pharma

Star Combo Pharma Limited specializes in the production and supply of health foods and dietary supplements, primarily serving markets in Australia and China. The company operates through two main divisions: Star Combo and Austoyou Retail, focusing on natural health supplements and skincare products.

Products and Services
  • Health foods and dietary supplements
  • Natural skincare products
  • E-commerce platform for health-conscious consumers
Growth Outlook
  • Expansion into the growing Chinese health supplement market
  • Increased online sales through dedicated e-commerce channels
  • Potential for new product lines in health and wellness
Financial Highlights
  • Recent quarterly revenue of 11.64 million AUD
  • Trailing twelve months (TTM) revenue of 46.73 million AUD
  • Dividend yield of 2.11% reflects shareholder returns
Star Combo Pharma Limited has positioned itself in a lucrative sector, focusing on health and wellness products that are increasingly in demand. The company's dual-market strategy allows it to leverage growth opportunities in both Australia and China, particularly through its e-commerce platform. Recent financial performance indicates a solid revenue stream, with the latest quarterly figures showing a revenue of 11.64 million AUD. Over the trailing twelve months, the company achieved a total revenue of 46.73 million AUD, demonstrating consistent performance. The dividend yield of 2.11% further highlights the company's commitment to returning value to shareholders. Overall, Star Combo Pharma Limited presents a compelling opportunity for investors interested in the health and wellness sector.
AI Generated • Oct 26, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Su Zhang, MBA

Website

www.starcombo.com.au

Headquarters

Smithfield, NSW 2164, AU

S66 Financials

Key Financial Metrics (TTM)

Gross Margin

21.17%

Operating Margin

-0.98%

Net Income Margin

1.67%

Return on Equity

1.02%

Return on Capital

-0.54%

Return on Assets

0.79%

Earnings Yield

2.07%

Dividend Yield

2.12%

Payout Ratio

1.27%

Stock Overview

Market Cap

A$18.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

135.00M

Volume

0

Avg. Volume

13.58K

Financials (TTM)

Gross Profit

A$11.26M

Operating Income

-A$416.16K

EBITDA

A$6.64M

Operating Cash Flow

A$15.22M

Capital Expenditure

-A$2.85M

Free Cash Flow

A$12.37M

Cash & ST Invst.

A$18.01M

Total Debt

A$4.19M

Star Combo Pharma Performance Analysis

Star Combo Pharma annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 24,700,2778.0%
20242024-06-30AUD 26,019,1015.3%
20252025-06-30AUD 27,811,5486.9%
20262026-06-30AUD 23,573,050-15.2%
Star Combo Pharma sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3015.4%
Q42025-06-30-25.2%
Q22025-12-310.2%
Q42026-06-30-2.4%
Star Combo Pharma annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.03469.2%
20242024-06-30AUD 0.01N/A
20252025-06-30AUD 0.04607.3%
20262026-06-30AUD 0.00-92.5%
Star Combo Pharma sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-30-56.5%
Q42025-06-301300.0%
Q22025-12-31-88.9%
Q42026-06-30-106.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$11.64M

-15.6%

Gross Profit

A$2.46M

-14.0%

Gross Margin

21.16%

N/A

Market Cap

A$18.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$630.01K

N/A

Employees

30

N/A

Net Income

-A$18.64K

-103.0%

EBITDA

A$7.31K

-99.3%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$18.01M

+144.8%

Total Debt

A$4.19M

+4.0%

Accounts Receivable

A$3.35M

-25.3%

Inventory

A$3.42M

-46.0%

Long Term Debt

A$3.89M

+0.5%

Short Term Debt

A$299.54K

+91.3%

Return on Assets

0.79%

N/A

Return on Invested Capital

-0.53%

N/A

Free Cash Flow

A$542.94K

+133.1%

Operating Cash Flow

A$2.70M

+428.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZNO.AXZoono Group Limited
A$0.05+2.17%
MBH.AXMaggie Beer Holdings Limited
A$0.05+0.00%
MCP.AXMcPherson's Limited
A$0.15+0.00%
AAP.AXAustralian Agricultural Projects Ltd
A$0.06+1.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$90.50+8.30%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$47.98-8.54%
TQQQProShares Trust - ProShares UltraPro Qqq
$68.43+3.23%
INTCIntel
$90.47+4.04%

Questions About S66

What is the current price of Star Combo Pharma?

Star Combo Pharma is trading at A$0.14 per share.

What is the 52-week range for Star Combo Pharma?

Over the past 52 weeks, Star Combo Pharma has traded between A$0.10 and A$0.28.

How much debt does Star Combo Pharma have?

As of the most recent reporting period, Star Combo Pharma reported total debt of A$4.19M.

How much cash does Star Combo Pharma have on hand?

Star Combo Pharma reported A$3.91M in cash and cash equivalents in its most recent financial results.

What is Star Combo Pharma’s dividend yield?

Star Combo Pharma currently has a dividend yield of 2.12%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services